Skip to content
Open access

Comparative predictive performance of different eGFR equations for 1-year major adverse cardiovascular events after percutaneous coronary intervention in patients with acute coronary syndrome

Sep 2026 · Frontiers in Cardiovascular Medicine · Vol 13 · 0 citations · 39 references
Medicine

TL;DR

Creatinine-based eGFR showed a stronger observed association with 1-year MACE after PCI than cystatin C–based eGFR in this single-center cohort; these findings do not establish clinical superiority of either equation and require external validation.

Abstract

Background Renal dysfunction is an important determinant of cardiovascular prognosis in patients with coronary artery disease. Estimated glomerular filtration rate (eGFR) is widely used to assess kidney function, but different equations may yield varying risk stratification results. This study aimed to compare the predictive performance of creatinine-based and cystatin C–based eGFR equations for 1-year major adverse cardiovascular events (MACE) in patients undergoing percutaneous coronary intervention (PCI). Methods This retrospective study included 560 patients who underwent PCI for acute coronary syndrome. Baseline clinical, laboratory, and echocardiographic variables were collected. Renal function was assessed using both creatinine-based and cystatin C–based eGFR equations. Logistic regression with backward selection based on the Akaike Information Criterion (AIC) was performed to identify independent predictors of 1-year MACE. In addition, multiple machine learning models were developed to evaluate predictive performance, and Shapley Additive Explanations (SHAP) analysis was applied to assess feature importance. Results During the 1-year follow-up, MACE occurred in 72 patients, comprising 71 repeat PCIs and one cardiac death. Equations relying on cystatin C detected a larger share of patients with impaired renal function compared with creatinine-based formulas. However, moderate-to-severe renal dysfunction defined by creatinine-based eGFR was significantly associated with an increased risk of 1-year MACE, although it was not retained as an independent predictor after AIC–based multivariable adjustment. Machine learning models demonstrated modest predictive performance overall, with logistic regression achieving the highest discriminative ability. SHAP analysis indicated that cardiovascular functional parameters and metabolic markers were the major contributors to risk prediction, while renal function indicators provided complementary prognostic information. Conclusions Creatinine-based eGFR showed a stronger observed association with 1-year MACE after PCI than cystatin C–based eGFR in this single-center cohort; these findings do not establish clinical superiority of either equation and require external validation. Renal function assessment remains an important component of cardiovascular risk stratification, and traditional regression models performed comparably to machine learning approaches in moderately sized clinical datasets.

Read PDF

Similar papers

Open access Sep 2026

Impact of differences in kidney function estimation by creatinine compared to cystatin C on clinical outcomes in patients with atrial fibrillation

Abstract Aims Differences between cystatin C-based and creatinine-based glomerular filtration rate estimations (eGFRdiff) have been associated with adverse outcomes. We aimed to investigate the prevalence of eGFRdiff and its association with clinical outcomes and brain lesions in patients with atrial fibrillation (AF)....

P. Krisai, M. Mutti, S. Aeschbacher et al. · 1 citation
Open access Sep 2026

Prognostic value of hemoglobin-to-serum creatinine ratio in patients with coronary artery disease and reduced kidney function following percutaneous coronary intervention

Objective This investigation sought to assess the prognostic significance of the hemoglobin-to-serum creatinine (Hb/SCr) ratio for long-term survival among patients with coexisting coronary artery disease (CAD) and reduced kidney function after percutaneous coronary intervention (PCI). Methods This retrospective study...

Si-Ni Fang, Huan-Ting Liu, You-Cheng Wang et al. · 0 citations
Open access Sep 2026

Impact of chronic kidney disease on long-term outcomes after left main percutaneous coronary intervention: a propensity score-matched analysis with up to 10 years of follow-up.

INTRODUCTION Chronic kidney disease (CKD) is a major determinant of adverse cardiovascular outcomes. Patients with CKD undergoing percutaneous coronary intervention (PCI) represent a particularly high-risk population; however, data on the long-term prognostic impact of CKD in patients treated with PCI for left main cor...

W. Skorupski, M. Grygier, M. Kałużna-Oleksy et al. · 0 citations
Open access Oct 2026

Risk factors for post-PCI restenosis in patients with coronary heart disease and the development and validation of a nomogram prediction model

This study aimed to analyze risk factors for in-stent restenosis (ISR) following percutaneous coronary intervention (PCI) in patients with coronary heart disease and develop and validate a nomogram prediction model. Clinical data were retrospectively collected from 1135 patients with coronary heart disease who underwen...

Xi-Na Jin, Zhen Dong, Dong-Sheng Chai · 0 citations
Open access Sep 2026

Prognostic Value of Composite Biomarkers Integrating Insulin Resistance and Coronary Inflammation for Major Adverse Cardiovascular Events in Post-PCI Patients with Coronary Artery Disease Across Glycemic Status: A Prospective Cohort Study

Background The study aimed to assess the prognostic utility of composite Insulin resistance (IR)- various inflammation biomarkers for predicting poor outcomes in coronary artery disease (CAD) patients stratified by glycemic status. Methods The prospective cohort included 1947 CAD patients undergoing PCI with pre-proced...

Zi-Xiang Ye, Chen-Yu Liu, En-Min Xie et al. · 0 citations
Open access Oct 2026

Prognostic Value of the Non-HDL-C/HDL-C Ratio for Predicting One-Year Major Adverse Cardiac and Cerebrovascular Events in Young Patients with Myocardial Infarction.

OBJECTIVE Young patients with myocardial infarction (MI) remain at risk for recurrent cardiovascular events despite favorable short-term outcomes. The prognostic significance of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol (non-HDL-C/HDL-C) ratio in this population remains insuff...

M. Keten, Kadir Bıyıklı · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.